Different neurotropic pathogens elicit neurotoxic CCR9- or neurosupportive CXCR3-expressing microglia

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• The precise mechanisms governing microglia's dual roles (destructive vs. constructive) in the central nervous system (CNS) are not fully understood.
• Microglia are key immune cells in the brain, implicated in both beneficial and detrimental processes in neurological disorders.

Purpose of the Study:

• To elucidate the distinct functional profiles and regulatory mechanisms of microglia in response to different CNS insults.
• To identify specific microglial subtypes associated with neurotoxic and neurosupportive functions.

Main Methods:

• Intracranial priming and rechallenging of mice with various neurotropic pathogens (Toxoplasma gondii, lymphocytic choriomeningitis virus) and CNS injury models.
• Utilizing small interfering RNA (siRNA) targeting CCR9 and/or Irg1 (immunoresponsive gene 1) to modulate microglial populations.
• Flow cytometry and cytokine analysis (TNF-alpha, IL-10, TGF-beta) to characterize microglial phenotypes and functions.

Main Results:

• Priming and rechallenging with Toxoplasma gondii induced neurotoxic CCR9+ Irg1+ microglia, resistant to apoptosis and producing high TNF-alpha.
• Lymphocytic choriomeningitis virus challenge elicited neurosupportive CXCR3+ Irg1- microglia, sensitive to apoptosis and producing IL-10 and TGF-beta.
• Administration of CCR9/Irg1 siRNA altered the frequencies and functions of these microglial subtypes in vivo, confirming their roles.

Conclusions:

• Two distinct microglial populations, neurotoxic (CCR9+ Irg1+) and neurosupportive (CXCR3+ Irg1-), can be bi-directionally elicited in the CNS.
• These findings provide novel insights into microglial involvement in neurodegenerative and neuroinflammatory diseases like Alzheimer's disease and AIDS dementia.
• Targeting these specific microglial pathways may offer therapeutic strategies for CNS disorders.